Patents by Inventor Amyn Pyarali Sayani

Amyn Pyarali Sayani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrazolo[3,4-b]pyridine compound, and its use as a PDE4 inhibitor
    Patent number: 7709497
    Abstract: The invention provides 4-{[1-(aminocarbonyl)-4-piperidinyl]amino}-N-[(3,4-dimethylphenyl)methyl]-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxamide, which is the compound of formula (I): or a salt thereof.
    Type: Grant
    Filed: March 15, 2005
    Date of Patent: May 4, 2010
    Assignee: Glaxo Group Limited
    Inventors: Siegfried Benjamin Christensen, IV, Caroline Mary Cook, Christopher David Edlin, Martin Redpath Johnson, Paul Spencer Jones, Mika Kristian Lindvall, Amyn Pyarali Sayani, Naimisha Trivedi, Lionel Trottet
  • Formulation containing anti-inflammatory androstane derivative
    Patent number: 7541350
    Abstract: There is provided a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) or a solvate thereof.
    Type: Grant
    Filed: August 13, 2004
    Date of Patent: June 2, 2009
    Assignee: Glaxo Group Limited
    Inventors: Keith Biggadike, Amyn Pyarali Sayani, Ian Richard Buxton, Kenton Lewis Reed
  • Pyrazolo[3,4-B]Pyridine Compound, and Its Use as a Pde4 Inhibitor
    Publication number: 20080255186
    Abstract: The invention provides N-{[1,6-diethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]methyl}-3-methyl-5-isoxazolecarboxamide or a salt thereof, such as the compound or a pharmaceutically acceptable salt thereof. The invention also provides the use of the compound or salt as an inhibitor of phosphodiesterase type IV (PDE4.
    Type: Application
    Filed: September 29, 2006
    Publication date: October 16, 2008
    Inventors: Siegfried Benjamin Christensen, Stuart Holman, Suzanne Elaine Keeling, Amyn Pyarali Sayani
  • Formulation containing anti-inflammatory androstane derivative
    Patent number: 6858596
    Abstract: There is provided a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) or a solvate thereof.
    Type: Grant
    Filed: February 4, 2002
    Date of Patent: February 22, 2005
    Assignee: SmithKline Beecham Corporation
    Inventors: Keith Biggadike, Amyn Pyarali Sayani, Ian Richard Buxton, Kenton Lewis Reed
  • Formulation containing anti-inflammatory androstane derivative
    Publication number: 20020165211
    Abstract: There is provided a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) 1
    Type: Application
    Filed: February 4, 2002
    Publication date: November 7, 2002
    Inventors: Keith Biggadike, Amyn Pyarali Sayani, Ian Richard Buxton, Kenton Lewis Reed